<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35584087</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1935-2735</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>PLoS neglected tropical diseases</Title>
          <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pulmonary haemorrhage as the earliest sign of severe leptospirosis in hamster model challenged with Leptospira interrogans strain HP358.</ArticleTitle>
        <Pagination>
          <StartPage>e0010409</StartPage>
          <MedlinePgn>e0010409</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0010409</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0010409</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe leptospirosis is challenging as it could evolve rapidly and potentially fatal if appropriate management is not performed. An understanding of the progression and pathophysiology of Leptospira infection is important to determine the early changes that could be potentially used to predict the severe occurrence of leptospirosis. This study aimed to understand the kinetics pathogenesis of Leptospira interrogans strain HP358 in the hamster model and identify the early parameters that could be used as biomarkers to predict severe leptospirosis.</AbstractText>
          <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">Male Syrian hamsters were infected with Leptospira interrogans strain HP358 and euthanized after 24 hours, 3, 4, 5, 6 and 7 days post-infection. Blood, lungs, liver and kidneys were collected for leptospiral detection, haematology, serum biochemistry and differential expression of pro- and anti-inflammatory markers. Macroscopic and microscopic organ damages were investigated. Leptospira interrogans strain HP358 was highly pathogenic and killed hamsters within 6-7 days post-infection. Pulmonary haemorrhage and blood vessel congestion in organs were noticed as the earliest pathological changes. The damages in organs and changes in biochemistry value were preceded by changes in haematology and immune gene expression.</AbstractText>
          <AbstractText Label="CONCLUSION/SIGNIFICANCE" NlmCategory="CONCLUSIONS">This study deciphered haemorrhage as the earliest manifestation of severe leptospirosis and high levels of IL-1β, CXCL10/IP-10, CCL3/MIP-α, neutrophils and low levels of lymphocytes and platelets serve as a cumulative panel of biomarkers in severe leptospirosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Philip</LastName>
            <ForeName>Noraini</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Priya</LastName>
            <ForeName>Sivan Padma</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>RAK College of Dental Sciences, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jumah Badawi</LastName>
            <ForeName>Ahmad Hussein</ForeName>
            <Initials>AH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohd Izhar</LastName>
            <ForeName>Mohd Hafidz</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Comparative Medicine and Technology Unit, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mohtarrudin</LastName>
            <ForeName>Norhafizah</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tengku Ibrahim</LastName>
            <ForeName>Tengku Azmi</ForeName>
            <Initials>TA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Preclinical Sciences, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sekawi</LastName>
            <ForeName>Zamberi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Neela</LastName>
            <ForeName>Vasantha Kumari</ForeName>
            <Initials>VK</Initials>
            <Identifier Source="ORCID">0000-0002-4076-8335</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Medical Microbiology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
        <NlmUniqueID>101291488</NlmUniqueID>
        <ISSNLinking>1935-2727</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007919" MajorTopicYN="Y">Leptospira</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007921" MajorTopicYN="Y">Leptospira interrogans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007922" MajorTopicYN="Y">Leptospirosis</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>13</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35584087</ArticleId>
        <ArticleId IdType="pmc">PMC9116642</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pntd.0010409</ArticleId>
        <ArticleId IdType="pii">PNTD-D-22-00140</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Vijayachari P, Sugunan AP, Singh SS, Mathur PP. Leptospirosis among the self-supporting convicts of Andaman Island during the 1920s—the first report on pulmonary haemorrhage in leptospirosis?
Indian J Med Res. 2015; 142(1):11–22. doi: 10.4103/0971-5916.162087
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0971-5916.162087</ArticleId>
            <ArticleId IdType="pmc">PMC4557245</ArticleId>
            <ArticleId IdType="pubmed">26261162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scoot GM, Coleman TJ. Leptospirosis. In: Cook C, Zumla AI, editors. Manson’s tropical diseases.
British: Saunders Elsevier; 2009. pp. 1161–7. doi: 10.1002/cphc.200800403
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cphc.200800403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day NPJ, Edward CN. 2010 Leptospirosis. In: Cohen J, Powderly WG, Opal SM, editors. Infectious diseases.
3rd ed. Britsih: Mosby Elsevier; 2010. pp. 1241–6.</Citation>
        </Reference>
        <Reference>
          <Citation>Watt G. Leptospirosis. In: Ryan E, Hill D, Solomon T, Magill A. Hunter’s tropical medicine and emerging infectious diseases. 9th ed.
British: Saunders Elsevier; 2013. pp 597–601.</Citation>
        </Reference>
        <Reference>
          <Citation>Hartskeerl RA, Wagenaar JF. Leptospirosis. In: Kasper DL, Fauci A, Hauser S, Longo D, Jameson J, editors. Harrison’s principles of internal medicine.
19th ed.
New York: McGraw-Hill Education; 2015. pp. 1140–5.</Citation>
        </Reference>
        <Reference>
          <Citation>Reis EA, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR, et al.. Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis. 2013; 7(9):e2457. doi: 10.1371/journal.pntd.0002457
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0002457</ArticleId>
            <ArticleId IdType="pmc">PMC3777885</ArticleId>
            <ArticleId IdType="pubmed">24069500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chirathaworn C, Kongpan S. Immune responses to Leptospira infection: roles as biomarkers for disease severity. Braz J Infect Dis. 2014; 18(1):77–81. doi: 10.1016/j.bjid.2013.08.002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjid.2013.08.002</ArticleId>
            <ArticleId IdType="pubmed">24275371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol. 2015; 387:65–97. doi: 10.1007/978-3-662-45059-8_5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-662-45059-8_5</ArticleId>
            <ArticleId IdType="pmc">PMC4442676</ArticleId>
            <ArticleId IdType="pubmed">25388133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cagliero J, Villanueva SYAM, Matsui M. Leptospirosis pathophysiology: Into the storm of cytokines. Front Cell Infect Microbiol. 2018; 8:204. doi: 10.3389/fcimb.2018.00204
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2018.00204</ArticleId>
            <ArticleId IdType="pmc">PMC6019470</ArticleId>
            <ArticleId IdType="pubmed">29974037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont H, Dupont–Perdrizet D, Perie JL. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997; 25(3):720–4. doi: 10.1086/513767
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/513767</ArticleId>
            <ArticleId IdType="pubmed">9314467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panaphut T, Domrongkitchaiporn S, Thinkamrop B. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis. 2002; 6(1):52–9. doi: 10.1016/s1201-9712(02)90137-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1201-9712(02)90137-2</ArticleId>
            <ArticleId IdType="pubmed">12044303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spichler AS, Vilaça PJ, Athanazio DA, Albuquerque JOM, Buzzar M, Castro B, et al.. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008; 79(6):911–4. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2640419</ArticleId>
            <ArticleId IdType="pubmed">19052303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fann RJ, Vidya RR, Chong HE, Indralingam V, Chan WSC. Clinical presentations and predictors of mortality for leptospirosis- a study from suburban area in Malaysia.
Med J Malaysia. 2020;75(1):52–6. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32008021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang HK, Lee MH, Chen YC, Hsueh PR, Chang SC. Factors associated with severity and mortality in patients with confirmed leptospirosis at a regional hospital in northern Taiwan. J Microbiol Immunol Infect. 2020; 53(2):307–14. doi: 10.1016/j.jmii.2018.05.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2018.05.005</ArticleId>
            <ArticleId IdType="pubmed">29934034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azhari NN, Ramli SNA, Joseph N, Philip N, Mustapha NF, Ishak SN, et al.. Molecular characterization of pathogenic Leptospira sp. in small mammals captured from the human leptospirosis suspected areas of Selangor state, Malaysia.
Acta Trop. 2018; 188:68–77. doi: 10.1016/j.actatropica.2018.08.020
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.actatropica.2018.08.020</ArticleId>
            <ArticleId IdType="pubmed">30145261</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philip N, Jani J, Azhari NN, Sekawi Z, Neela V.K. In vivo and in silico virulence analysis Leptospira species isolated from environments and rodents in leptospirosis outbreak areas in Malaysia.
Front Microbiol. 2021; 12:753328. doi: 10.3389/fmicb.2021.753328
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2021.753328</ArticleId>
            <ArticleId IdType="pmc">PMC8602918</ArticleId>
            <ArticleId IdType="pubmed">34803975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsui M, Rouleau V, Bruyere-Ostells L, Goarant C. Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun.
2011; 79(11):4480–92. doi: 10.1128/IAI.05727-11
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.05727-11</ArticleId>
            <ArticleId IdType="pmc">PMC3257942</ArticleId>
            <ArticleId IdType="pubmed">21844232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vernel-Pauillac F, Goarant C. Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis. 2010; 4(1):e582. doi: 10.1371/journal.pntd.0000582
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0000582</ArticleId>
            <ArticleId IdType="pmc">PMC2797601</ArticleId>
            <ArticleId IdType="pubmed">20076757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villanueva SY, Saito M, Tsutsumi Y, Segawa T, Baterna RA, Chakraborty A, et al.. High virulence in hamsters of four dominant Leptospira serovars isolated from rats in the Philippines. Microbiology. 2014;160(2):418–28. doi: 10.1099/mic.0.072439-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.072439-0</ArticleId>
            <ArticleId IdType="pubmed">24257815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marinho M, Oliveira-Júnior IS, Monteiro CM, Perri SH, Salomão R. 2009. Pulmonary disease in hamsters infected with Leptospira interrogans: histopathologic findings and cytokine mRNA expressions. Am J Trop Med Hyg. 2009; 80(5):832–6. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19407133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoddard RA, Gee JE, Wilkins PP, McCaustland K, Hoffmaster AR. 2009. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the lipL32 gene. Diagn Microbiol Infect Dis. 2009; 64(3):247–55. doi: 10.1016/j.diagmicrobio.2009.03.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2009.03.014</ArticleId>
            <ArticleId IdType="pubmed">19395218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vernel-Pauillac F, Merien F. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect Immun. 2006; 74(7):4172–9. doi: 10.1128/IAI.00447-06
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00447-06</ArticleId>
            <ArticleId IdType="pmc">PMC1489750</ArticleId>
            <ArticleId IdType="pubmed">16790792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsui M, Roche L, Geroult S, Soupé-Gilbert ME, Monchy D, Huerre M, et al.. Cytokine and chemokine expression in kidneys during chronic leptospirosis in reservoir and susceptible animal models. PLoS One. 2016; 11(5):e0156084. doi: 10.1371/journal.pone.0156084
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0156084</ArticleId>
            <ArticleId IdType="pmc">PMC4878748</ArticleId>
            <ArticleId IdType="pubmed">27219334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect. 2006; 12(4):299–300. doi: 10.1111/j.1469-0691.2005.01335.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2005.01335.x</ArticleId>
            <ArticleId IdType="pubmed">16524404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hinjoy S, Kongyu S, Doung-Ngern P, Doungchawee G, Colombe SD, Tsukayama R, et al.. Environmental and behavioral risk factors for severe leptospirosis in Thailand.
Trop Med Infect Dis. 2019; 4(2):79. doi: 10.3390/tropicalmed4020079
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/tropicalmed4020079</ArticleId>
            <ArticleId IdType="pmc">PMC6631942</ArticleId>
            <ArticleId IdType="pubmed">31100812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spichler A, Moock M, Chapola EG, Vinetz J. Weil’s disease: an unusually fulminant presentation characterized by pulmonary hemorrhage and shock. Braz J Infect Dis. 2005; 9(4):336–40. doi: 10.1590/s1413-86702005000400011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/s1413-86702005000400011</ArticleId>
            <ArticleId IdType="pubmed">16270127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gulati S, Gulati A. Pulmonary manifestations of leptospirosis. Lung India. 2012; 29(4):347–53. doi: 10.4103/0970-2113.102822
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0970-2113.102822</ArticleId>
            <ArticleId IdType="pmc">PMC3519021</ArticleId>
            <ArticleId IdType="pubmed">23243349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Predescu A, Diaconu S, Tiuca N, Purcareanu A, Tomescu A, Cuciureanu D, et al.. Leptospirosis-a case report. Internal Medicine. 2018; 15(4):45–53.</Citation>
        </Reference>
        <Reference>
          <Citation>Haake DA. Hamster model of leptospirosis. Curr Protoc Microbiol. 2006; 2(1):12E–2. doi: 10.1002/9780471729259.mc12e02s02
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/9780471729259.mc12e02s02</ArticleId>
            <ArticleId IdType="pmc">PMC2667198</ArticleId>
            <ArticleId IdType="pubmed">18770576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coutinho ML, Matsunaga J, Wang LC, de la Peña Moctezuma A, Lewis MS, Babbitt JT, et al.. Kinetics of Leptospira interrogans infection in hamsters after intradermal and subcutaneous challenge.
PLoS Negl Trop Dis. 2014; 8(11):e3307. doi: 10.1371/journal.pntd.0003307
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003307</ArticleId>
            <ArticleId IdType="pmc">PMC4239013</ArticleId>
            <ArticleId IdType="pubmed">25411782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nikaido Y, Ogawa M, Fukuda K, Yokoyama M, Kanemaru T, Nakayama T, et al.. Transbronchial invasion and proliferationof Leptospira interrogans in lung without inflammatory cell infiltration in a hamster model. Infect Immun. 2019; 87(12):e00727–19. doi: 10.1128/IAI.00727-19
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00727-19</ArticleId>
            <ArticleId IdType="pmc">PMC6867870</ArticleId>
            <ArticleId IdType="pubmed">31548321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnacle J, Gurney S, Ledot S, Singh S. Leptospirosis as an important differential of pulmonary haemorrhage on the intensive care unit: a case managed with VV-ECMO.
J Intensive Care.
2020; 8(1):1–7. doi: 10.1186/s40560-020-00447-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40560-020-00447-2</ArticleId>
            <ArticleId IdType="pmc">PMC6939335</ArticleId>
            <ArticleId IdType="pubmed">31908779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gouveia EL, Metcalfe J, de Carvalho ALF, Aires TSF, Villasboas-Bisneto JC, Queirroz A, et al.. Leptospirosis-associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis. 2008; 14(3):505–8. doi: 10.3201/eid1403.071064
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1403.071064</ArticleId>
            <ArticleId IdType="pmc">PMC2570821</ArticleId>
            <ArticleId IdType="pubmed">18325275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen P, Raftery S, Phelan D. Massive pulmonary haemorrhage due to leptospirosis.
Intensive Care Med. 1989; 15:322–4. doi: 10.1007/BF00263869
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00263869</ArticleId>
            <ArticleId IdType="pubmed">2768647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong WH, Chen Z. Leptospirosis with pulmonary haemorrhage and multiple organ failure: a case report and literature review. J Int Med Res. 2021; 49(5):1–9. doi: 10.1177/03000605211019665
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/03000605211019665</ArticleId>
            <ArticleId IdType="pmc">PMC8165534</ArticleId>
            <ArticleId IdType="pubmed">34044641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wunder EA, Figueira CP, Benaroudj N, Hu B, Tong BA, Trajtenberg F, et al.. A novel flagellar sheath protein, FcpA, determines filament coiling, translational motility and virulence for the Leptospira spirochete. Mol Microbiol. 2016;101(3):457–470. doi: 10.1111/mmi.13403
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.13403</ArticleId>
            <ArticleId IdType="pmc">PMC4979076</ArticleId>
            <ArticleId IdType="pubmed">27113476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang B, Sullivan JA, Sullivan GW, Mandell GL. Role of specific antibody in interaction of leptospires with human monocytes and monocyte-derived macrophages. Infect Immun. 1984; 46(3):809–13. doi: 10.1128/iai.46.3.809-813.1984
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.46.3.809-813.1984</ArticleId>
            <ArticleId IdType="pmc">PMC261617</ArticleId>
            <ArticleId IdType="pubmed">6500713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isogai E, Isogai H, Wakizaka H, Miura H, Kurebayashi Y. Chemiluminescence and phagocytic responses of rat polymorphonuclear neutrophils to leptospires. Zentralbl Bakteriol. 1989; 272(1):36–46. doi: 10.1016/s0934-8840(89)80090-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0934-8840(89)80090-8</ArticleId>
            <ArticleId IdType="pubmed">2610812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scharrig E, Carestia A, Ferrer MF, Cedola M, Pretre G, Drut R, et al.. Neutrophil extracellular traps are involved in the innate immune response to infection with Leptospira.
PloS Negl Trop Dis. 2015; 9(7):e0003927. doi: 10.1371/journal.pntd.0003927
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003927</ArticleId>
            <ArticleId IdType="pmc">PMC4498591</ArticleId>
            <ArticleId IdType="pubmed">26161745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vieira ML, Teixeira AF, Pidde G, Ching ATC, Tambourgi DV, Nascimento A, et al.. Leptospira interrogans outer membrane protein LipL21 is a potent inhibitor of neutrophil myeloperoxidase.
Virulence. 2018; 9(1):414–25. doi: 10.1080/21505594.2017.1407484
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21505594.2017.1407484</ArticleId>
            <ArticleId IdType="pmc">PMC5955187</ArticleId>
            <ArticleId IdType="pubmed">29235397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charo N, Scharrig E, Ferrer MF, Sanjuan N, Carrera Silva EA, Schattner M, et al.. Leptospira species promote a pro-inflammatory phenotype in human neutrophils. Cell Microbiol. 2019; 21(2):e12990. doi: 10.1111/cmi.12990
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12990</ArticleId>
            <ArticleId IdType="pubmed">30537301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raffray L, Giry C, Vandroux D, Fayeulle S, Moiton MP, Gerber A, et al.. The monocytosis during human leptospirosis is associated with modest immune cell activation states. Med Microbiol Immunol. 2019; 208(5):667–78. doi: 10.1007/s00430-018-0575-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00430-018-0575-9</ArticleId>
            <ArticleId IdType="pubmed">30542761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isogai E, Kitagawa H, Isogai H, Matsuzawa T, Shimizu T, Yanagihara Y, et al.. Effects of leptospiral lipopolysaccharide on rabbit platelets. Zentralbl Bakteriol. 1989; 271(2):186–96. doi: 10.1016/s0934-8840(89)80072-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0934-8840(89)80072-6</ArticleId>
            <ArticleId IdType="pubmed">2775427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, et al.. The clearance mechanism of chilled blood platelets. Cell. 2003; 112(1):87–97. doi: 10.1016/s0092-8674(02)01253-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0092-8674(02)01253-9</ArticleId>
            <ArticleId IdType="pubmed">12526796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tunjungputri RN, Gasem MH, van der Does W, Sasongko PH, Isbandrio B, Urbanus RT, et al.. Platelet dysfunction contributes to bleeding complications in patients with probable leptospirosis.
PLoS Negl Trop Dis. 2017; 11(9):e0005915. doi: 10.1371/journal.pntd.0005915
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0005915</ArticleId>
            <ArticleId IdType="pmc">PMC5626517</ArticleId>
            <ArticleId IdType="pubmed">28934202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang JQ, Imran M, Hu WL, Ojcius DM, Li Y, Ge YM, et al.. vWA proteins of Leptospira interrogans induce hemorrhage in leptospirosis by competitive inhibition of vWF/GPIb-mediated platelet aggregation. EBioMedicine. 2018; 37:428–41. doi: 10.1016/j.ebiom.2018.10.033
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2018.10.033</ArticleId>
            <ArticleId IdType="pmc">PMC6284457</ArticleId>
            <ArticleId IdType="pubmed">30337247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vieira ML, Nascimento ALTO. Virulent Leptospira interrogans induce cytotoxic effects in human platelets in vitro through direct interactions. Front Microbiol.
2020; 11:572972. doi: 10.3389/fmicb.2020.572972
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2020.572972</ArticleId>
            <ArticleId IdType="pmc">PMC7552899</ArticleId>
            <ArticleId IdType="pubmed">33117318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards CN, Nicholson GD, Everard CO. Thrombocytopenia in leptospirosis. Am J Trop Med Hyg. 1982; 31(4):827–9. doi: 10.4269/ajtmh.1982.31.827
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4269/ajtmh.1982.31.827</ArticleId>
            <ArticleId IdType="pubmed">7102918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casiple LC. Thrombocytopenia and bleeding in leptospirosis. Phil J Microbiol Infect Dis. 1998; 27(1):18–22.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicodemo AC, Duarte MI, Alves VA, Takakura CF, Santos RT, Nicodemo EL. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am J Trop Med Hyg. 1997; 56(2):181–7. doi: 10.4269/ajtmh.1997.56.181
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4269/ajtmh.1997.56.181</ArticleId>
            <ArticleId IdType="pubmed">9080878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaureguiberry S, Roussel M, Brinchault-Rabin G, Gacouin A, Le Meur A, Arvieux C, et al.. Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin microbiol Infect. 2005; 11(5):391–4. doi: 10.1111/j.1469-0691.2005.01148.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2005.01148.x</ArticleId>
            <ArticleId IdType="pmc">PMC7129073</ArticleId>
            <ArticleId IdType="pubmed">15819866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craig SB, Graham GC, Burns MA, Dohnt MF, Smythe LD, McKay DB. Haematological and clinical-chemistry markers in patients presenting with leptospirosis: a comparison of the findings from uncomplicated cases with those seen in the severe disease. Ann Trop Med Parasitol. 2009; 103(4):333–41. doi: 10.1179/136485909X435058
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1179/136485909X435058</ArticleId>
            <ArticleId IdType="pubmed">19508751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craig SB, Collet TA, Wynwood SJ, Smythe LD, Weier SL, McKay DB. Neutrophil counts in leptospirosis patients infected with different serovars. Trop Biomed. 2013; 30(4):579–83. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24522125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Silva NL, Niloofa MJR, Fernando N, Karunanayake L, Rodrigo C, De Silva HJ, et al.. Changes in full blood count parameters in leptospirosis: a prospective study. Int Arch Med. 2014; 7(1):1–4. doi: 10.1186/1755-7682-7-1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1755-7682-7-1</ArticleId>
            <ArticleId IdType="pmc">PMC3882287</ArticleId>
            <ArticleId IdType="pubmed">24387244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George T, Pais MLJ, Adnan M, Pereira R, Jakribettu RP, Baliga MS. Clinicolaboratory profile of leptospirosis: Observations from a tertiary care hospital.
J Appl Hematol.
2020; 11(3):102–7. 10.4103/joah.joah_11_20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/joah.joah_11_20</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daher EF, Lima RS, Junior GBS, Silva EC, Karbage NN, Kataoka RS, et al..Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil. Braz J Infect Dis. 2010; 14(1):3–10. .</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20428646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goswami RP, Goswami RP, Basu A, Tripathi SK, Chakrabarti S, Chattopadhyay I. Predictors of mortality in leptospirosis: an observational study from two hospitals in Kolkata, eastern India. Trans R Soc Trop Med Hyg. 2014;108(12):791–6. doi: 10.1093/trstmh/tru144
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/trstmh/tru144</ArticleId>
            <ArticleId IdType="pubmed">25359320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Divakar A, Pillai MGK, Thomas E. Clinical profile of mortality predictors in leptospirosis: a prospective study in a tertiary care center. Int J Med Res Rev 2017; 5(9):857–64. 10.17511/ijmrr.2017.i09.05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17511/ijmrr.2017.i09.05</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandhu RS, Ismail HB, Ja’afar MH, Rampal S. The predictive factors for severe leptospirosis cases in Kedah.
Trop Med Infect Dis. 2020;5(2):79. doi: 10.3390/tropicalmed5020079
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/tropicalmed5020079</ArticleId>
            <ArticleId IdType="pmc">PMC7344897</ArticleId>
            <ArticleId IdType="pubmed">32422911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Fost M, Chierakul W, Limpaiboon R, Dondorp A, White NJ, van Der Poll T. Release of granzymes and chemokines in Thai patients with leptospirosis. Clin Microbiol Infect. 2007; 13(4):433–6. doi: 10.1111/j.1469-0691.2006.01640.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2006.01640.x</ArticleId>
            <ArticleId IdType="pubmed">17359329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyriakidis I, Samara P, Papa A. Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil’s syndrome. Cytokine. 2011; 54(2):117–20. doi: 10.1016/j.cyto.2011.01.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2011.01.014</ArticleId>
            <ArticleId IdType="pubmed">21316985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senavirathna I, Rathish D, Agampodi A. Cytokine response in human leptospirosis with different clinical outcomes: a systematic review. BMC Infect Dis. 2020; 20(1):268. doi: 10.1186/s12879-020-04986-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-020-04986-9</ArticleId>
            <ArticleId IdType="pmc">PMC7137275</ArticleId>
            <ArticleId IdType="pubmed">32264832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomizawa R, Sugiyama H, Sato R, Ohnishi M, Koizumi N. Male-specific pulmonary hemorrhage and cytokine gene expression in golden hamster in early-phase Leptospira interrogans serovar Hebdomadis infection. Microb Pathog. 2017; 111:33–40. doi: 10.1016/j.micpath.2017.08.016
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2017.08.016</ArticleId>
            <ArticleId IdType="pubmed">28811249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowanitchapat A, Payungporn S, Sereemaspun A, Ekpo P, Phulsuksombati D, Poovorawan Y, et al.. Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira. Comp Immunol Microbiol Infect Dis. 2010; 33(5):423–34. doi: 10.1016/j.cimid.2009.05.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cimid.2009.05.001</ArticleId>
            <ArticleId IdType="pubmed">19559480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medeiros FR, Spichler A, Athanazio DA. Leptospirosis associated disturbances of blood vessels, lungs and hemostasis. Acta Trop. 2010; 115(1–2):155–62. doi: 10.1016/j.actatropica.2010.02.016
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.actatropica.2010.02.016</ArticleId>
            <ArticleId IdType="pubmed">20206112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luks AM, Lakshminarayanan S, Hirschmann JV. Leptospirosis presenting as diffuse alveolar hemorrhage–case report and literature review.
Chest. 2003; 123(2):639–43. doi: 10.1378/chest.123.2.639
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.123.2.639</ArticleId>
            <ArticleId IdType="pubmed">12576395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dolhnikoff M, Mauad T, Bethlem EP, Carvalho CR. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis. 2007; 11(1): 142–8. doi: 10.1590/s1413-86702007000100029
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/s1413-86702007000100029</ArticleId>
            <ArticleId IdType="pubmed">17625743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Croda J, Neto AN, Brasil RA, Pagliari C, Nicodemo AC, Duarte MIS. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect.
2010; 16(6):593–9. doi: 10.1111/j.1469-0691.2009.02916.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2009.02916.x</ArticleId>
            <ArticleId IdType="pubmed">19778300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Brito T, Aiello VD, da Silva LFF, da Silva AMG, da Silva WLF, Castelli JB, et al.. Human hemorrhagic pulmonary leptospirosis: pathological findings and pathophysiological correlations. PloS one. 2013; 8(8):e71743. doi: 10.1371/journal.pone.0071743
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0071743</ArticleId>
            <ArticleId IdType="pmc">PMC3741125</ArticleId>
            <ArticleId IdType="pubmed">23951234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva JJ, Dalston MO, Carvalho JE, Setubal S, Oliveira JM, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis.
Rev Soc Bras Med Trop. 2002; 35(4):395–9. doi: 10.1590/s0037-86822002000400017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/s0037-86822002000400017</ArticleId>
            <ArticleId IdType="pubmed">12170336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evangelista K, Franco R, Schwab A, Coburn J. Leptospira interrogans binds to cadherins. PLoS Negl Trop Dis. 2014; 8(1):e2672. doi: 10.1371/journal.pntd.0002672
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0002672</ArticleId>
            <ArticleId IdType="pmc">PMC3907533</ArticleId>
            <ArticleId IdType="pubmed">24498454</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evangelista KV, Hahn B, Wunder EA Jr, Ko AI, Haake DA, Coburn J. Identification of cell-binding adhesins of Leptospira interrogans. PLoS Negl Trop Dis. 2014; 8(10):e3215. doi: 10.1371/journal.pntd.0003215
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003215</ArticleId>
            <ArticleId IdType="pmc">PMC4183468</ArticleId>
            <ArticleId IdType="pubmed">25275630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez-Lopez DG, Fahey M, Coburn J. Responses of human endothelial cells to pathogenic and non-pathogenic Leptospira species.
PLoS Negl Trop Dis. 2010; 4(12):e918. doi: 10.1371/journal.pntd.0000918
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0000918</ArticleId>
            <ArticleId IdType="pmc">PMC3001904</ArticleId>
            <ArticleId IdType="pubmed">21179504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Q, Wang Q, Zhu J, Xiao Q, Zhang L. Reactive oxygen species: key regulators in vascular health and diseases. Br J Pharmacol. 2018; 175(8):1279–92. doi: 10.1111/bph.13828
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bph.13828</ArticleId>
            <ArticleId IdType="pmc">PMC5867026</ArticleId>
            <ArticleId IdType="pubmed">28430357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011; 11(8):519–31. doi: 10.1038/nri3024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3024</ArticleId>
            <ArticleId IdType="pubmed">21785456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finder J, Stark WW Jr, Nakayama DK, Geller D, Wasserloos K, Pitt BR, et al.. TGF-beta regulates production of NO in pulmonary artery smooth muscle cells by inhibiting expression of NOS. Am J Physiol. 1995; 268(5):L862–7. doi: 10.1152/ajplung.1995.268.5.L862
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.1995.268.5.L862</ArticleId>
            <ArticleId IdType="pubmed">7539224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vodovotz Y.
Control of nitric oxide production by transforming growth factor-β1: mechanistic insights and potential relevance to human disease. Nitric oxide. 1997; 1(1):3–17. doi: 10.1006/niox.1996.0105
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/niox.1996.0105</ArticleId>
            <ArticleId IdType="pubmed">9701040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology. 2012; 122(1):55–68. doi: 10.1159/000338150
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000338150</ArticleId>
            <ArticleId IdType="pubmed">22722323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruckdorfer KR, Dee G, Jacobs M, Rice-Evans CA. The protective action of nitric oxide against membrane damage induced by myoglobin radicals. Bio-chem Soc Trans. 1990; 18(2):285–6. doi: 10.1042/bst0180285
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bst0180285</ArticleId>
            <ArticleId IdType="pubmed">2379721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Von Knethen A, Brüne B. Activation of peroxisome proliferator-activated receptor γ by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst. J Immunol. 2002; 169(5):2619–26. doi: 10.4049/jimmunol.169.5.2619
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.169.5.2619</ArticleId>
            <ArticleId IdType="pubmed">12193733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pautz A, Art S, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010; 23(2):211–67. doi: 10.1016/j.niox.2010.04.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.niox.2010.04.007</ArticleId>
            <ArticleId IdType="pubmed">20438856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowenstein CJ, Padalko E. iNOS (NOS2) at a glance. J Cell Sci. 2004; 117(14):2865–7. doi: 10.1242/jcs.01166
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.01166</ArticleId>
            <ArticleId IdType="pubmed">15197240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>d’Andon MF, Quellard N, Fernandez B, Ratet G, Lacroix-Lamandé S, Vandewalle A, et al.. Leptospira interrogans induces fibrosis in the mouse kidney through Inos-dependent, TLR-and NLR-independent signaling pathways. Plos Negl Trop Dis. 2014; 8(1):e2664. doi: 10.1371/journal.pntd.0002664
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0002664</ArticleId>
            <ArticleId IdType="pmc">PMC3907306</ArticleId>
            <ArticleId IdType="pubmed">24498450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pretre G, Olivera N, Cedola M, Haase S, Alberdi L, Brihuega B, et al.. Role of inducible nitric oxide synthase in the pathogenesis of experimental leptospirosis. Microb Pathog. 2011; 51(3):203–8. doi: 10.1016/j.micpath.2011.03.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micpath.2011.03.011</ArticleId>
            <ArticleId IdType="pubmed">21497651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avdeeva MG, Bondarenko IN, Peredirii IR. Clinical significance of the activity of nitric oxide synthase in patients with leptospirosis. Klin Lab Diagn. 2008; 1:40–3. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18314776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cordonin C, Turpin M, Bascands JL, Dellagi K, Mavingui P, Tortosa P, et al.. Three Leptospira strains from western Indian ocean wildlife show highly distinct virulence phenotypes through hamster experimental infection. Front Microbiol.
2019; 10:382. doi: 10.3389/fmicb.2019.00382
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.00382</ArticleId>
            <ArticleId IdType="pmc">PMC6421516</ArticleId>
            <ArticleId IdType="pubmed">30915044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacNee W.
ABC of chronic obstructive pulmonary disease: Pathology, pathogenesis, and pathophysiology. BMJ. 2006; 332(7551):1202–1204.</Citation>
        </Reference>
        <Reference>
          <Citation>Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol. 2005; 32(4):311–8. doi: 10.1165/rcmb.2004-0309OC
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2004-0309OC</ArticleId>
            <ArticleId IdType="pubmed">15668323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Churg A, Zhou S, Wang X, Wang R, Wright JL. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol. 2009; 40(4):482–90. doi: 10.1165/rcmb.2008-0038OC
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2008-0038OC</ArticleId>
            <ArticleId IdType="pubmed">18931327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couillin I, Vasseur V, Charron S, Gasse P, Tavernier M, Guillet J, et al.. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol. 2009; 183(12):8195–202. doi: 10.4049/jimmunol.0803154
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0803154</ArticleId>
            <ArticleId IdType="pubmed">20007584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pauwels NS, Bracke KR, Dupont LL, Pottelberge GRV, Provoost S, Berghe TV, et al.. Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011; 38(5):1019–28. doi: 10.1183/09031936.00158110
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00158110</ArticleId>
            <ArticleId IdType="pubmed">21622588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpio C, Villasante C, Galera R, Romero D, de Cos A, Hernanz A, et al.. Systemic inflammation and higher perception of dyspnea mimicking asthma in obese subjects. J Allergy Clin Immunol. 2016; 137(3):718–26. doi: 10.1016/j.jaci.2015.11.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2015.11.010</ArticleId>
            <ArticleId IdType="pubmed">26768410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou Y, Chen X, Liu J, Zhou DB, Kuang X, Xiao J, et al.. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Int J Chron Obstruct Pulmon Dis. 2017; 12:1247–54. doi: 10.2147/COPD.S131877
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/COPD.S131877</ArticleId>
            <ArticleId IdType="pmc">PMC5413485</ArticleId>
            <ArticleId IdType="pubmed">28490868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neville LF, Mathiak G, Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev. 1997; 8(3):207–19. doi: 10.1016/s1359-6101(97)00015-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1359-6101(97)00015-4</ArticleId>
            <ArticleId IdType="pubmed">9462486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maurer M, von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004; 36(10):1882–6. doi: 10.1016/j.biocel.2003.10.019
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2003.10.019</ArticleId>
            <ArticleId IdType="pubmed">15203102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vazirinejad R, Ahmadi Z, Arababadi MK, Hassanshahi G, Kennedy D. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2014; 21(6):322–30. doi: 10.1159/000357780
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000357780</ArticleId>
            <ArticleId IdType="pubmed">24642726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhavsar I, Miller CS, Al-Sabbagh M. Macrophage inflammatory protein-1 alpha (MIP-1 alpha)/CCL3: as a biomarker. In: Preedy VR, Patel VB, editors. General methods in biomarker research and their applications. Switzerland: Springer Nature; 2015.pp. 223–49.</Citation>
        </Reference>
        <Reference>
          <Citation>Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012; 76(1):16–32. doi: 10.1128/MMBR.05015-11
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MMBR.05015-11</ArticleId>
            <ArticleId IdType="pmc">PMC3294426</ArticleId>
            <ArticleId IdType="pubmed">22390970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao HQ, Li WM, Lu ZQ, Sheng ZY, Yao YM. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis. J. Interferon Cytokine Res. 2015; 35(4):242–51. doi: 10.1089/jir.2014.0119
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/jir.2014.0119</ArticleId>
            <ArticleId IdType="pubmed">25517926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen J.
The immunopathogenesis of sepsis. Nature. 2002; 420(6917):885–91. doi: 10.1038/nature01326
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature01326</ArticleId>
            <ArticleId IdType="pubmed">12490963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tajiki MH, Nakama ASY, Salomão R. The ratio of plasma levels Of Il-10/Tnf-alpha and its relationship to disease severity and survival in patients with leptospirosis. Braz J Infect Dis. 1997; 1(3):138–41. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11105129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mikulski M, Boisier P, Lacassin F, Soupe-Gilbert ME, Mauron C, Bruyere-Ostells L, et al.. Severity markers in severe leptospirosis: a cohort study. Eur J clin Microbiol Infect Dis. 2015; 34(4):687–95. doi: 10.1007/s10096-014-2275-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2275-8</ArticleId>
            <ArticleId IdType="pubmed">25413923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ittyachen AM. Covid-19 and leptospirosis: Cytokine storm and the use of steroids. Trop Doct. 2021; 51(1):128–30. doi: 10.1177/0049475520971425
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0049475520971425</ArticleId>
            <ArticleId IdType="pubmed">33236692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett MR, Devarajan P. Proteomic analysis of acute kidney injury: biomarkers to mechanisms. Proteomics Clin Appl. 2011; 5(1–2):67–77. doi: 10.1002/prca.201000066
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/prca.201000066</ArticleId>
            <ArticleId IdType="pmc">PMC3049245</ArticleId>
            <ArticleId IdType="pubmed">21280238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johann DJ Jr, Veenstra TD. Multiple biomarkers in molecular oncology. Expert Rev Mol Diagn. 2007; 7:223–5. doi: 10.1586/14737159.7.3.223
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737159.7.3.223</ArticleId>
            <ArticleId IdType="pubmed">17489728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chirathaworn C, Supputtamongkol Y, Lertmaharit S, Poovorawan Y. Cytokine levels as biomarkers for leptospirosis patients. Cytokine. 2016; 85:80–2. doi: 10.1016/j.cyto.2016.06.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2016.06.007</ArticleId>
            <ArticleId IdType="pubmed">27295614</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
